These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 9517440

  • 1. Antipsychotic regulation of dopamine D1, D2 and D3 receptor mRNA.
    D'Souza U, McGuffin P, Buckland PR.
    Neuropharmacology; 1997; 36(11-12):1689-96. PubMed ID: 9517440
    [Abstract] [Full Text] [Related]

  • 2. Differential effects of clozapine and haloperidol on dopamine receptor mRNA expression in rat striatum and cortex.
    Damask SP, Bovenkerk KA, de la Pena G, Hoversten KM, Peters DB, Valentine AM, Meador-Woodruff JH.
    Brain Res Mol Brain Res; 1996 Sep 05; 41(1-2):241-9. PubMed ID: 8883957
    [Abstract] [Full Text] [Related]

  • 3. Clozapine and sulpiride up-regulate dopamine D3 receptor mRNA levels.
    Buckland PR, O'Donovan MC, McGuffin P.
    Neuropharmacology; 1993 Sep 05; 32(9):901-7. PubMed ID: 7901792
    [Abstract] [Full Text] [Related]

  • 4. Changes in dopamine D1, D2 and D3 receptor mRNA levels in rat brain following antipsychotic treatment.
    Buckland PR, O'Donovan MC, McGuffin P.
    Psychopharmacology (Berl); 1992 Sep 05; 106(4):479-83. PubMed ID: 1349752
    [Abstract] [Full Text] [Related]

  • 5. Phenotypic characterization of neuroleptic-sensitive neurons in the forebrain: contrasting targets of haloperidol and clozapine.
    Guo N, Vincent SR, Fibiger HC.
    Neuropsychopharmacology; 1998 Aug 05; 19(2):133-45. PubMed ID: 9629567
    [Abstract] [Full Text] [Related]

  • 6. Up-regulation of D3 dopamine receptor mRNA by neuroleptics.
    Wang W, Hahn KH, Bishop JF, Gao DQ, Jose PA, Mouradian MM.
    Synapse; 1996 Jul 05; 23(3):232-5. PubMed ID: 8807752
    [Abstract] [Full Text] [Related]

  • 7. Effect of chronic treatment with typical and atypical neuroleptics on the expression of dopamine D2 and D3 receptors in rat brain.
    Hurley MJ, Stubbs CM, Jenner P, Marsden CD.
    Psychopharmacology (Berl); 1996 Dec 05; 128(4):362-70. PubMed ID: 8986007
    [Abstract] [Full Text] [Related]

  • 8. Lack of effect of chronic antipsychotic treatment on dopamine D5 receptor mRNA level.
    Buckland PR, O'Donovan MC, McGuffin P.
    Eur Neuropsychopharmacol; 1992 Dec 05; 2(4):405-9. PubMed ID: 1362660
    [Abstract] [Full Text] [Related]

  • 9. Dopamine D3 receptors are not involved in the induction of c-fos mRNA by neuroleptic drugs: comparison of the dopamine D3 receptor antagonist GR103691 with typical and atypical neuroleptics.
    Hurley MJ, Stubbs CM, Jenner P, Marsden CD.
    Eur J Pharmacol; 1996 Dec 30; 318(2-3):283-93. PubMed ID: 9016916
    [Abstract] [Full Text] [Related]

  • 10. Subchronic administration of clozapine, but not haloperidol or metoclopramide, decreases dopamine D2 receptor messenger RNA levels in the nucleus accumbens and caudate-putamen in rats.
    See RE, Lynch AM, Sorg BA.
    Neuroscience; 1996 May 30; 72(1):99-104. PubMed ID: 8730709
    [Abstract] [Full Text] [Related]

  • 11. Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol.
    Markianos M, Hatzimanolis J, Lykouras L.
    Eur Arch Psychiatry Clin Neurosci; 2001 Jun 30; 251(3):141-6. PubMed ID: 11697576
    [Abstract] [Full Text] [Related]

  • 12. Effects of acute or long-term treatment with chlorpromazine, haloperidol or sulpiride on neuropeptide Y-like immunoreactivity concentrations in the nucleus accumbens of rat.
    Obuchowicz E, Turchan J.
    Eur Neuropsychopharmacol; 1999 Jan 30; 9(1-2):51-9. PubMed ID: 10082228
    [Abstract] [Full Text] [Related]

  • 13. The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: cellular localization and pharmacological characterization.
    Deutch AY, Duman RS.
    Neuroscience; 1996 Jan 30; 70(2):377-89. PubMed ID: 8848147
    [Abstract] [Full Text] [Related]

  • 14. Dopamine D3 receptor modulation of dopamine efflux in the rat nucleus accumbens.
    Roberts C, Cummins R, Gnoffo Z, Kew JN.
    Eur J Pharmacol; 2006 Mar 18; 534(1-3):108-14. PubMed ID: 16490190
    [Abstract] [Full Text] [Related]

  • 15. Long-term treatment with chlorpromazine and haloperidol but not with sulpiride and clozapine markedly elevates neuropeptide Y-like immunoreactivity in the rat hypothalamus.
    Obuchowicz E.
    Neuropeptides; 1996 Oct 18; 30(5):471-8. PubMed ID: 8923510
    [Abstract] [Full Text] [Related]

  • 16. Opposing roles for dopamine D2 and D3 receptors on neurotensin mRNA expression in nucleus accumbens.
    Diaz J, Lévesque D, Griffon N, Lammers CH, Martres MP, Sokoloff P, Schwartz JC.
    Eur J Neurosci; 1994 Aug 01; 6(8):1384-7. PubMed ID: 7981879
    [Abstract] [Full Text] [Related]

  • 17. Upregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model.
    Mahmoudi S, Lévesque D, Blanchet PJ.
    Mov Disord; 2014 Aug 01; 29(9):1125-33. PubMed ID: 24838395
    [Abstract] [Full Text] [Related]

  • 18. Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment.
    Tarazi FI, Florijn WJ, Creese I.
    Neuroscience; 1997 Jun 01; 78(4):985-96. PubMed ID: 9174067
    [Abstract] [Full Text] [Related]

  • 19. Differential effects of dopamine antagonists on evoked dopamine release from slices of striatum and nucleus accumbens in rats.
    Yamada S, Takaki T, Yokoo H, Tanaka M.
    J Pharm Pharmacol; 1995 Mar 01; 47(3):259-62. PubMed ID: 7602493
    [Abstract] [Full Text] [Related]

  • 20. Effects of haloperidol on the expression of lymphocyte dopamine receptor mRNAs in the rat.
    Caronti B, Passarelli F, Calderaro C, Palladini G, Pontieri FE.
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Jul 01; 23(5):851-9. PubMed ID: 10509379
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.